John Ferguson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

A new test may get to the heart of your dementia risk several years before any symptoms emerge. Dementia, which affects over 6 million Americans, impacts memory, language and problem-solving skills.

A small study found that a blood test could identify whether someone had Chronic Fatigue Syndrome (CFS) with 92% accuracy. Because CFS and long COVID have some biological overlap, this research could ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Share on Pinterest Scientists are getting closer to accurately and quickly diagnosing chronic fatigue syndrome. Santi Nuñez/Stocksy There is no single test to diagnose chronic fatigue syndrome (CFS), ...

Sarah Annesley receives funding from ME Research UK, The Judith Jane Mason & Harold Stannett Williams Memorial Foundation and the Medical Research Future Fund (MRFF035120). Scientists in the United ...

Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...